Skip to main content
Equibles
CON logo

CON · Concentra Group Holdings Parent, Inc. · Metrics

Track CON — free

Use CON with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CON.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$40.59 +0.59 (+1.48%) At close · Oct 28 Q2 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.18B
Shares
127.52M
Volume · Oct 28 779.17K Avg daily vol (3M) 1.02M

CON metrics

107 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$40.59
Market cap
$5.18B

Price action

20 metrics
Price change (1W)
+3.2%
Price change (30D)
+13.1%
Price change (3M)
+22.4%
Price change (6M)
+77.3%
Price change (YTD)
+103.3%
Price change (1Y)
+92.4%
Trailing year
Price change (5Y)
—
52-week high
$40.20
52-week low
$18.71
Change from 52-week high
-0.5%
Change from 52-week low
+113.8%
Annualized volatility
28.2%
Annualized volatility (3M)
33.4%
Beta
0.4
RSI (14D)
69.2
Price vs SMA 50
+11.2%
Price vs SMA 200
+41.9%
Avg volume (3M)
1.02M
Relative volume
1.0
Average dollar volume
$36.40M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
127.52M

Valuation

12 metrics
P / E (TTM)
25.8
Trailing earnings · reciprocal yield 3.9%
PEG ratio
0.6
EV / revenue
2.8×
reciprocal yield 35.1%
EV / EBITDA
14.3×
reciprocal yield 7.0%
EV / EBIT
17.4×
reciprocal yield 5.8%
P / sales
2.2×
reciprocal yield 44.8%
P / book
10.7
reciprocal yield 9.4%
FCF yield
5.2%
TTM · current market cap
Buyback yield
—
P / FCF
19.1
reciprocal yield 5.2%
P / operating cash flow
15.2
reciprocal yield 6.6%
Earnings yield
3.9%

Historical valuation

8 metrics
P / E historical average (3Y)
17.7×
reciprocal yield 5.7%
P / E historical average (5Y)
17.7×
reciprocal yield 5.7%
EV / revenue historical average (3Y)
2.1×
reciprocal yield 47.2%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 47.2%
EV / EBIT historical average (3Y)
13.4×
reciprocal yield 7.5%
EV / EBIT historical average (5Y)
13.4×
reciprocal yield 7.5%
EV / EBITDA historical average (3Y)
11.0×
reciprocal yield 9.1%
EV / EBITDA historical average (5Y)
11.0×
reciprocal yield 9.1%

Dividends & buybacks

7 metrics
Dividend yield
0.6%
Trailing 12 months
Payout ratio
16.1%
Shareholder yield
0.6%
Dividend / share (TTM)
$0.25
Dividend growth YoY
+0.0%
Dividend growth streak
1
Last ex-dividend
2026-08-20

Earnings calendar

2 metrics
Next earnings
2026-11-06
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
—
Operating margin
16.4%
Trailing 12 months
Net margin
8.7%
Gross profit (TTM)
—
Operating profit (TTM)
$374.81M
Net income (TTM)
$198.73M
Trailing 12 months
Diluted EPS (TTM)
$1.55
FCF margin
11.7%
Effective tax rate
23.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$17.83
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$2.92
EBITDA per diluted share (TTM)
$3.54
Net income per diluted share (TTM)
$1.55
Operating cash flow per diluted share (TTM)
$2.62
Free cash flow per diluted share (TTM)
$2.09
Capital expenditures per diluted share (TTM)
$0.53
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.11
Book value per share
$3.06

Growth

11 metrics
Revenue growth YoY
+10.0%
Year over year
Net income growth YoY
+46.5%
Revenue (TTM)
$2.29B
Trailing 12 months
EPS growth YoY
+45.7%
Shares change YoY
-0.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
-6.7%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-4.8%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
41.7%
Return on assets
6.6%
Debt / equity
3.3
Current ratio
1.4
EBITDA (TTM)
$454.56M
Free cash flow (TTM)
$267.42M
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
3.1
Return on invested capital
15.2%
Trailing 12 months
Net cash
−$1.42B
Latest balance sheet
Cash & equivalents
$158.04M
Total assets
$3.01B
Total debt
$1.57B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$335.55M
Capital expenditures (TTM)
$68.13M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$14.20M
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

9 metrics
13F filers
292
13F filer change QoQ
+13
Institutional ownership
87.7%
Conviction holders (share of 13F filers)
0.3%
Crowding (high-turnover and private-fund holders)
32.4%
Private-fund adviser ownership
31.8%
Active holders' share change QoQ
+2.1%
Holder tenure
6.6
Price vs estimated holder cost
+37.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
26.6%

Short interest

3 metrics
Short interest
2.8%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.14M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 2014596 CUSIP 20603L102 13F (30d) 83 filings 82 filers Visit website Investor relations